Marktanalyse - Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logistics Infrastructure

Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logistics Infrastructure

Summary

GlobalData’s report, 'Paradigm Shift in R&D from Small Molecules to Biologics and Need for More Efficient Logistics Infrastructure” provides key update on the paradigm shift of comapnies from small molecules to biologics and the need to more robust and efficient logistics infrastructure.

Scope

- Data and information on the shift of companies from small molecules to biologics and consequently the need for more efficient logistics.

Reasons to buy

- Develop understanding about the shift of companies from small molecules to biologics which is demanding a more robust and efficient logistic system.

1 Table of Contents

1 Table of Contents 1

1.1 List of Tables 1

1.2 List of Figures 1

2 Summary 1

3 Pipeline Products: Past & Future 1

3.1 Pipeline Products: Past 1

3.2 Pipeline Products: Future 2

3.3 Why Shift to Biologics? 2

3.4 Differences Between Biologics and Chemical-Based Drugs 3

3.5 Logistics — A Key Component in the Development and Commercialization of Biologics 6

3.5.1 Role of Logistics during Biologic Development — Preclinical 6

3.5.2 Role of Logistics after Development of the Biologic — Commercialization 6

3.5.3 Importance of Logistics 6

3.5.4 Common Logistics Issues 7

4 Appendix 8

4.1 Methodology 8

4.1.1 Coverage 8

4.1.2 Secondary Research 8

4.1.3 Primary Research 8

4.1.4 Expert Panel Validation 8

4.2 Contact Us 9

4.3 Disclaimer 9



1.1 List of Tables

Table 1: Chemical Based vs Biologics — Number of Products Launched in the Past Five years 2

Table 2: Chemical Based vs Biologics — Number of Products in Various Phases of Development 2

Table 3: Chemical Based vs Biologics — Major Differences 4

Table 4: Chemical Based vs Biologics — Major Differences 5

Table 5: Common Logistics Issues 7



1.2 List of Figures

Figure 1: Chemical Based vs. Biologics — Trend over Past Five Years 2

Figure 2: Chemical Based vs. Biologics — Future Trend 2

• Calming and Sleeping in Argentina
• Calming and Sleeping in Canada
• Calming and Sleeping in Denmark
• Calming and Sleeping in Guatemala
• Calming and Sleeping in Hong Kong, China
• Calming and Sleeping in Norway
• Calming and Sleeping in Turkey
• Cough, Cold and Allergy (Hay Fever) Remedies in Argentina
• Cough, Cold and Allergy (Hay Fever) Remedies in Canada
• Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
• Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala
• Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
• Cough, Cold and Allergy (Hay Fever) Remedies in Norway
• Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia
• Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
• Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
• Ear Care in Argentina
• Ear Care in Canada
• Ear Care in Denmark
• Ear Care in Hong Kong, China